Company
Products
Services
News
Downloads
Contact Us
Home Page
Cambridge Life Sciences - Immunology - Inflammatory Bowel Disease (IBD)
Search  
Immunology Clinical Chemistry Urease Hp Tests Instrumentation
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) and Crohn's Disease (CD)

Anti-Neutrophil Cytoplasmic Antibodies (ANCA)

Inflammatory Bowel Disease (IBD) are characterised by chronic inflammation and ulceration of the intestine. Atypical pANCA have been reported to occur in patients with IBD and primary sclerosing cholangitis (PSC). Studies have shown that ~80% of patients with NC and PSC and ~25% of patients with Crohn's disease have pANCA. Atypical pANCA occur in patients with UC. Bacterial permealising increasing factor (BPI) is one of the antigens associated with a pANCA reaction in patients with UC.


Immunofluorescence Assays
 
Code
Name
Description
Determinations
1116 ImmuGlo ANCA IFA Kit 4 x 6 well hPMN ethanol fixed

24

1140 ImmuGlo ANCA IFA Kit 8 x 6 well hPMN ethanol fixed

48

1141 ImmuGlo pANCA IFA Kit 8 x 6 well hPMN formalin fixed

48

1142 ImmuGlo COMVI ANCA IFA Kit 8 x 6 + 6 well hPMN ethanol and formalin fixed

48

2189 ImmuGlo ANCA COMVI Slide ethanol and formalin fixed hPMN cells

6+6 well

2162 ImmuGlo ANCA Slide 6 well ethanol fixed hPMN cells

6 well

2186 ImmuGlo pANCA Slide 6 well formalin fixed hPMN cells

6 well

2252 ImmuGlo ANCA positive control  

0.5mL

2240 ImmuGlo pANCA positive control  

0.5mL

2220 ImmuGlo negative control  

0.5mL

2100 ImmuGlo IgG FITC Conjugate anti-human IgG for Indirect IF

5.0mL

For technical information on Immco products please click here or contact us.

Anti-Saccharomyces Cerevisiae Antibodies (ASCA)

Differentation of Crohn's Disease (CD) and Ulcerative Colitis (UC) can be problematic clinically. ASCA and ANCA studies are useful in screening tests for IBD in differentiating UC from CD and in proper identification of patients with indeterminate colitis.

The staining pattern of ANCA in IBD is atypical pANCA. The prevalence of pANCA in UC is 50-80% while in CD the prevalence is 10-20%. In contrast, ASCA occur primarily in CD (50-60%) and rarely in UC.

D-tek BlueWell Elisa

Code
Name
Description
Determinations
ASCA02-96 ASCA IgA Elisa Anti Saccharomyces Cerevisiae IgA antibody Elisa

96

ASCG02-96 ASCA IgG Elisa Anti Saccharomyces Cerevisiae IgG antibody Elisa

96

ASCS02-96 ASCA IgA/IgG Screen Elisa Anti Saccharomyces Cerevisiae IgA/IgG antibody Elisa

96

For technical information on D-tek products please click here or contact us.

Please select another Immunology option:

Immunology     Clinical Chemistry    Urease Hp Tests     Instrumentation